Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study

ConclusionSwitching prandial insulin to insulin glulisine resulted in improved effectiveness with 43.6% of T1DM and 39.6% of T2DM patients reaching their individual pre-defined HbA1c target within 1  year. Switching was safe and was associated with a low rate of hypoglycaemia and adverse events.Trial Registrationhttps://awbdb.bfarm.de; Identifier: 6818; Date of registration: 23.06.2016
Source: Diabetes Therapy - Category: Endocrinology Source Type: research